Dr. Surbhi Sidana is an Assistant Professor of Medicine at Stanford University and specializes in the treatment of multiple myeloma and related disorders. Dr Sidana leads the myeloma cellular therapy program and the myeloma disease focused group within the BMT and Cell Therapy Division at Stanford. Dr. Sidana has an active clinical research portfolio and leads clinical trials, especially those focusing on CAR-T cell therapy, immunotherapy and transplantation in myeloma. Her work on CAR-T therapy focuses on clinical trials, as well as understanding the patient experience and side effects amongst patients receiving CAR-T therapy.